In addition to providing coverage of these drugs for obesity, which would be a new indication in Medicare and in most states under Medicaid, these efforts will also allow beneficiaries in participating states and Part D plans to access GLP-1s for obesity at a lower out-of-pocket cost than if they were to purchase them with cash at the direct-to-consumer prices offered by the manufacturers
Realistic expectations: Some thinning may occur despite best efforts if youre losing weight rapidly
The question of building muscle on GLP-1 is important because the caloric deficit created by these medications can work against muscle growth
1, citing the high costs of the drugs
Ordering and interpreting them is your provider's job
The peptide activates G protein-coupled receptor pathways, triggering glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, and central appetite regulation